Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesBPH-related symptoms improve with PDE-5 inhibitor
Urology Times, 06/11/09
Guttman C - Findings from a multicenter, randomized, double-blind, placebo-controlled study are consistent with previously reported data showing that tadalafil (Cialis) improves lower urinary tract symptoms associated with BPH. However, the benefit cannot be explained by effects on pressure-flow urodynamics. A pilot study in men with LUTS secondary to BPH incorporating uroflow measurements to investigate this effect was undertaken, but improvements in flow rates were not observed. The present study was undertaken as a rigorous evaluation of pressure-flow urodynamics.
Related Articles
The Impact of Diabetes Type 2 in the Pathogenesis of Benign Prostatic Hyperplasia: A Review
Advances in Urology, 11/10/09
Relevance Score: 85%
Association of Codon 10 Polymorphism of the Transforming Growth Factor Beta 1 Gene with Prostate Cancer and Hyperplasia in an Iranian Population
Urologia Internationalis, 10/16/09
Relevance Score: 84%
Significant Complications following Minimally Invasive Office-Based Treatments for BPH: Experience from a Tertiary Care Center
Current Urology, 11/13/09
Relevance Score: 82%
Intraprostatic injection of botulinum toxin A: A promising treatment for patients with benign prostatic hyperplasia
Indian Journal of Urology, 10/05/09
Relevance Score: 82%
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
Cochrane Reviews, 10/20/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder
Urology, 12/08/09
Clinical aspects and epidemiology of uncomplicated cystitis in women-German results of the ARESC Study
Der Urologe, 12/08/09
Efficacy and Tolerability of Fesoterodine in Men With Overactive Bladder: A Pooled Analysis of 2 Phase III Studies
Urology, 12/07/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Frequency of CYP1B1 homozygous genotype 355T/T in prostate cancer families from Poland
European Journal of Cancer Prevention, 12/08/09
The Unintended Burden of Increased Prostate Cancer Detection Associated With Prostate Cancer Screening and Diagnosis
Urology, 12/08/09
Prostate Histotripsy in an Anticoagulated Model
Urology, 12/08/09
Today in Voiding Dys/Incontinence...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder
Urology, 12/08/09
Age, gender, and voided volume dependency of peak urinary flow rate and uroflowmetry nomogram in the Indian population
Indian Journal of Urology, 12/08/09
Predicting Success in the Endoscopic Management of Pediatric Vesicoureteral Reflux
Urology, 12/08/09
Article Search
Sponsor